High-sensitivity Troponin I in Stable Patients With Atherosclerotic Disease in the TRA2°P-TIMI 50 Trial

被引:0
|
作者
Eisen, Alon
Bonaca, Marc P.
Jarolim, Petr
Scirica, Benjamin M.
Bohula, Erin A.
Murphy, Sabina A.
Braunwald, Eugene
Morrow, David A.
机构
关键词
Ischemic heart disease; Troponin I; Myocardial infarction;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
18549
引用
收藏
页数:4
相关论文
共 50 条
  • [21] UNIVERSAL CLASSIFICATION SYSTEM TYPE OF INCIDENT MYOCARDIAL INFARCTION IN PATIENTS WITH STABLE ATHEROSCLEROSIS: OBSERVATIONS FROM TRA 2°P-TIMI 50
    Kidd, Stephen
    Bonaca, Marc
    Scirica, Benjamin
    Murphy, Sabina
    Braunwald, Eugene
    Morrow, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1568 - A1568
  • [22] Vorapaxar in Patients with Prior Ischemic Stroke: Primary Results from the Stroke Cohort of the Multinational TRA 2°P-TIMI 50 Trial
    Morrow, David A.
    Alberts, Mark
    Mohr, Jay P.
    Ameriso, Sebastian
    Bonaca, Marc
    Goto, Shinya
    Hankey, Graeme J.
    Murphy, Sabina
    Scirica, Benjamin
    Teal, Philip
    Braunwald, Eugene
    STROKE, 2013, 44 (02)
  • [23] Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial
    Qamar, Arman
    Morrow, David A.
    Creager, Mark A.
    Scirica, Benjamin M.
    Olin, Jeffrey W.
    Beckman, Joshua A.
    Murphy, Sabina A.
    Bonaca, Marc P.
    VASCULAR MEDICINE, 2020, 25 (02) : 124 - 132
  • [24] EFFICACY AND SAFETY OF VORAPAXAR FOR SECONDARY PREVENTION IN OLDER PATIENTS: OBSERVATIONS FROM TRA 2°P-TIMI 50
    Kidd, Stephen K.
    Bonaca, Marc
    Scirica, Benjamin
    Goodrich, Erica
    Murphy, Sabina
    Braunwald, Eugene
    Morrow, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2098 - 2098
  • [25] New Ischemic Stroke and Outcomes With Vorapaxar Versus Placebo Results From the TRA 2°P-TIMI 50 Trial
    Bonaca, Marc P.
    Scirica, Benjamin M.
    Braunwald, Eugene
    Wiviott, Stephen D.
    Goto, Shinya
    Nilsen, Dennis W.
    Bonarjee, Vernon
    Murphy, Sabina A.
    Morrow, David A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (22) : 2318 - 2326
  • [26] Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P-TIMI 50 trial
    Freedman, Benjamin L. L.
    Berg, David D. D.
    Scirica, Benjamin M. M.
    Bohula, Erin A. A.
    Goodrich, Erica L. L.
    Sabatine, Marc S. S.
    Morrow, David A. A.
    Bonaca, Marc P. P.
    CLINICAL CARDIOLOGY, 2023, 46 (03) : 348 - 349
  • [27] Efficacy and safety of vorapaxar for secondary prevention in low body weight in patients with atherosclerosis: analyses from the TRA 2°P-TIMI 50 Trial
    Xu, Haiyan
    Bonaca, Marc P.
    Goodrich, Erica
    Scirica, Benjamin M.
    Morrow, David A.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2021, 10 (02) : 190 - 199
  • [28] Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)
    Bonaca, Marc P.
    Gutierrez, J. Antonio
    Creager, Mark A.
    Scirica, Benjamin M.
    Olin, Jeffrey
    Murphy, Sabina A.
    Braunwald, Eugene
    Morrow, David A.
    CIRCULATION, 2016, 133 (10) : 997 - 1005
  • [29] Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
    Scirica, Benjamin M.
    Bonaca, Marc P.
    Braunwald, Eugene
    De Ferrari, Gaetano M.
    Isaza, Daniel
    Lewis, Basil S.
    Mehrhof, Felix
    Merlini, Piera A.
    Murphy, Sabina A.
    Sabatine, Marc S.
    Tendera, Michal
    Van de Werf, Frans
    Wilcox, Robert
    Morrow, David A.
    LANCET, 2012, 380 (9850): : 1317 - 1324
  • [30] New Ischemic Stroke and Outcomes with Vorapaxar vs. Placebo: Results from TRA 2°P-TIMI 50 Trial
    Bonaca, Marc P.
    Scirica, Benjamin M.
    Braunwald, Eugene
    Wiviott, Stephen D.
    Goto, Shinya
    Nilsen, Dennis
    Bonarjee, Vernon
    Murphy, Sabina A.
    Morrow, David A.
    CIRCULATION, 2012, 126 (21)